High-definition Transcranial Direct Current Stimulation (HD-tDCS) Verbal Learning

Verbal Learning and Memory Clinical Trial

Official title:

Enhancing Verbal Learning and Memory Using High-Definition Transcranial Direct Current Stimulation (HD-tDCS)

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01733576
• Other study ID #: CB64
• Status: Completed
• Phase: Phase 0
• First received: November 26, 2012
• Last updated: July 21, 2015

Study information

• Verified date: July 2015
• Source: The University of New South Wales
• Contact: n/a
• Is FDA regulated: No
• Health authority: Australia: Therapeutic Goods Administration
• Study type: Interventional

Clinical Trial Summary

This project will use a new form of non-invasive brain stimulation called high-definition transcranial direct current stimulation (HD-tDCS) to facilitate verbal learning. This form of stimulation is similar to transcranial direct current stimulation (tDCS) but allows for more spatially focused stimulation. We hypothesise that HD-tDCS when applied to regions of the brain important for learning and memory will improve verbal learning and memory compared to sham HD-tDCS.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 16
• Est. primary completion date: March 2014
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years to 40 Years

Eligibility

Inclusion Criteria:

• Ages 18 - 40 years

• Right-handed

Exclusion Criteria:

• concurrent medication likely to affect mental performance

• current history of drug or alcohol abuse or dependence

• any psychiatric or neurological disorder, recent head injury, or history of seizure or stroke.

Study Design

Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Basic Science

Related Conditions & MeSH terms

• Verbal Learning and Memory

Intervention

Device:
• HD-tDCS

Locations

Country	Name	City	State
Australia	Black Dog Institute	Sydney	New South Wales

Sponsors (1)

Lead Sponsor	Collaborator
The University of New South Wales

Country where clinical trial is conducted

Australia, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Ray Auditory Verbal Learning Test (RAVLT)			No